JP2002526530A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526530A5
JP2002526530A5 JP2000574510A JP2000574510A JP2002526530A5 JP 2002526530 A5 JP2002526530 A5 JP 2002526530A5 JP 2000574510 A JP2000574510 A JP 2000574510A JP 2000574510 A JP2000574510 A JP 2000574510A JP 2002526530 A5 JP2002526530 A5 JP 2002526530A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
conh
alkylene
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574510A
Other languages
English (en)
Japanese (ja)
Other versions
JP4544746B2 (ja
JP2002526530A (ja
Filing date
Publication date
Priority claimed from DE19845406A external-priority patent/DE19845406C2/de
Application filed filed Critical
Publication of JP2002526530A publication Critical patent/JP2002526530A/ja
Publication of JP2002526530A5 publication Critical patent/JP2002526530A5/ja
Application granted granted Critical
Publication of JP4544746B2 publication Critical patent/JP4544746B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000574510A 1998-10-02 1999-09-18 置換された1,3−ジアリール−2−ピリド−2−イル−3−(ピリド−2−イルアミノ)プロパノール誘導体、その製造方法、それを含有する医薬およびその使用 Expired - Fee Related JP4544746B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19845406.6 1998-10-02
DE19845406A DE19845406C2 (de) 1998-10-02 1998-10-02 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PCT/EP1999/006933 WO2000020393A1 (de) 1998-10-02 1999-09-18 Substituierte 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Publications (3)

Publication Number Publication Date
JP2002526530A JP2002526530A (ja) 2002-08-20
JP2002526530A5 true JP2002526530A5 (enExample) 2006-09-07
JP4544746B2 JP4544746B2 (ja) 2010-09-15

Family

ID=7883187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574510A Expired - Fee Related JP4544746B2 (ja) 1998-10-02 1999-09-18 置換された1,3−ジアリール−2−ピリド−2−イル−3−(ピリド−2−イルアミノ)プロパノール誘導体、その製造方法、それを含有する医薬およびその使用

Country Status (22)

Country Link
US (1) US6596728B1 (enExample)
EP (1) EP1117642B1 (enExample)
JP (1) JP4544746B2 (enExample)
KR (1) KR100609255B1 (enExample)
CN (1) CN1173951C (enExample)
AR (1) AR021845A1 (enExample)
AT (1) ATE267809T1 (enExample)
AU (1) AU757689B2 (enExample)
BR (1) BR9915027B1 (enExample)
CA (1) CA2345985C (enExample)
CZ (1) CZ299569B6 (enExample)
DE (2) DE19845406C2 (enExample)
DK (1) DK1117642T3 (enExample)
ES (1) ES2219066T3 (enExample)
HU (1) HU226688B1 (enExample)
ID (1) ID29249A (enExample)
PL (1) PL205034B1 (enExample)
PT (1) PT1117642E (enExample)
RU (1) RU2224748C2 (enExample)
TR (1) TR200100896T2 (enExample)
WO (1) WO2000020393A1 (enExample)
ZA (1) ZA200102587B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2431995A1 (en) 2000-12-21 2002-06-27 Aventis Pharma Deutschland Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
DE10064402A1 (de) * 2000-12-21 2002-06-27 Aventis Pharma Gmbh Diphenylazetidinonderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
JP2005505538A (ja) * 2001-08-22 2005-02-24 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング アリール置換プロパノールアミン誘導体と他の活性成分との組み合わせ物およびその使用
US7161008B2 (en) * 2002-05-03 2007-01-09 Sanofi - Aventis Deutschland GmbH Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them
DE10219987A1 (de) * 2002-05-03 2004-04-08 Aventis Pharma Deutschland Gmbh Optisch aktive β-Aminoketone, optisch aktive 1,3-Aminoalkohole und Verfahren zu deren Herstellung
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
US7816353B2 (en) * 2003-10-24 2010-10-19 Exelixis, Inc. P70S6 kinase modulators and method of use
EP4137137A1 (en) 2010-05-26 2023-02-22 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EA038594B1 (ru) 2011-10-28 2021-09-21 Шайр Хьюман Дженетик Терапис, Инк. Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
KR20160002773A (ko) 2013-03-15 2016-01-08 루메나 파마수티컬즈, 인코포레이티드 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
JP6361168B2 (ja) * 2013-06-17 2018-07-25 Jsr株式会社 液晶配向剤、液晶配向膜、液晶表示素子、液晶表示素子の製造方法、重合体及び化合物
EP4424363B1 (en) 2019-02-12 2026-04-29 Mirum Pharmaceuticals, Inc. Methods for increasing growth in pediatric subjects having cholestatic liver disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000816A1 (en) * 1977-08-06 1979-02-21 Beecham Group Plc Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
SU1194273A3 (ru) * 1981-02-09 1985-11-23 Пфайзер Инк (Фирма) Способ получени пирбутерола или его аналогов
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
ES2098570T3 (es) * 1992-02-22 1997-05-01 Hoechst Ag Amidas de un acido 4-amino-2-ureido-pirimidina-5-carboxilico, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
DE19845402B4 (de) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
ATE268758T1 (de) 1997-04-04 2004-06-15 Aventis Pharma Gmbh Hypolipidämische propanolaminderivate
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung

Similar Documents

Publication Publication Date Title
JP2010530881A5 (enExample)
JP2004503501A5 (enExample)
NO175939C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv N1-(1,2-cis-2-halogencyklopropyl)-substituerte pyridonkarboksylsyrederivater, eller et farmasöytisk akseptabelt salt derav, eventuelt i en stereoisomerisk form
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
JP2001526218A5 (enExample)
JP2005508905A5 (enExample)
JP2005525398A5 (enExample)
JP2005505583A5 (enExample)
KR960701007A (ko) 피롤-아미딘계 화합물 및 약제학적으로 허용 가능한 그 염, 그 제조방법 및 상기 화합물을 포함하는 약제조성물
JP2002526539A5 (enExample)
RU2224748C2 (ru) Производные 1,3-диарил-2-пиридин-2-ил-3-(пиридин-2-иламино)пропанола и фармацевтическая композиция на их основе
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием
RU2004107854A (ru) Производные 4[пиперидин-4-илиден-(3-карбомоилфенил)метил]бензамида и их применение для лечении боли, спинальных повреждений или желудочно-кишечных расстройств
NO924949D0 (no) Piperidylsubstituerte indoler
RU2006130686A (ru) Новые пиперидины в качестве модуляторов хемокинов (ccr)
RU2001111841A (ru) Замещенные производные 1,3-диарил-2-пиридин-2-ил-3-(пиридин-2-иламино)пропанола, способ их получения, содержащие эти соединения лекарственные средства и их применение
FR2549049B1 (fr) Nouvelles amidines, leur procede de preparation et leur application therapeutique
DE60127535D1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
JP2002526550A5 (enExample)
JP2002538117A5 (enExample)
JP2004538314A5 (enExample)
RU2004134563A (ru) 2,5-дизамещенная 3-меркаптопентановая кислота
FI872930A0 (fi) Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi
BR0009080A (pt) Método de tratamento da apnéia do sono
JP2007525527A5 (enExample)